Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine

Effective management of melanoma depends heavily on early diagnosis. When detected in early non-metastatic stages, melanoma is almost 100% curable by surgical resection, however when detected in late metastatic stages III and IV, 5-year survival rates drop to ~50% and 10–25%, respectively, due to li...

Descripción completa

Detalles Bibliográficos
Autores principales: Mumford, Sophie L., Towler, Benjamin P., Pashler, Amy L., Gilleard, Onur, Martin, Yella, Newbury, Sarah F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022922/
https://www.ncbi.nlm.nih.gov/pubmed/29701682
http://dx.doi.org/10.3390/biom8020021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022922/
https://www.ncbi.nlm.nih.gov/pubmed/29701682
http://dx.doi.org/10.3390/biom8020021

Ejemplares similares